AU2002219247A1 - Use of levosimendan for treating erictile dysfunction - Google Patents

Use of levosimendan for treating erictile dysfunction

Info

Publication number: AU2002219247A1
Authority: AU; Australia
Prior art keywords: erictile; levosimendan; dysfunction; treating; treating erictile
Prior art date: 2000-12-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002219247A

Inventor

Lasse Lehtonen

Jyrki Lilleberg

Pertti Pentikainen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Orion Oyj

Original Assignee

Orion Oyj

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-15

Filing date

2001-12-14

Publication date

2002-06-24

2001-12-14 Application filed by Orion Oyj filed Critical Orion Oyj

2002-06-24 Publication of AU2002219247A1 publication Critical patent/AU2002219247A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002219247A 2000-12-15 2001-12-14 Use of levosimendan for treating erictile dysfunction Abandoned AU2002219247A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FI20002755		2000-12-15
FI20002755A FI20002755A0 (en)	2000-12-15	2000-12-15	Method of therapy for erectile dysfunction
PCT/FI2001/001101 WO2002047603A2 (en)	2000-12-15	2001-12-14	Use of levosimendan for treating erictile dysfunction

Publications (1)

Publication Number	Publication Date
AU2002219247A1 true AU2002219247A1 (en)	2002-06-24

Family

ID=8559724

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002219247A Abandoned AU2002219247A1 (en)	2000-12-15	2001-12-14	Use of levosimendan for treating erictile dysfunction

Country Status (6)

Country	Link
US (1)	US7115604B2 (en)
EP (1)	EP1349551A2 (en)
AU (1)	AU2002219247A1 (en)
CA (1)	CA2431125C (en)
FI (1)	FI20002755A0 (en)
WO (1)	WO2002047603A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11969424B2 (en)	2019-12-16	2024-04-30	Tenax Therapeutics, Inc.	Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1252603B (en)	1990-04-19	1995-06-19	Giorgio Cavallini	2,4-DIAMINO-6 PIPERIDINO PIRIMIDINA-3 TOPICAL OXIDE ON THE GLAND IN THE TREATMENT OF ERECTILE IMPOTENCES
GB2251615B (en) *	1991-01-03	1995-02-08	Orion Yhtymae Oy	(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en)	1992-05-06	1993-11-17	Orion Yhtymae Oy	Compounds for use as anti-ischemic medicaments
US5565466A (en) *	1993-08-13	1996-10-15	Zonagen, Inc.	Methods for modulating the human sexual response
DE4338948A1 (en)	1993-11-15	1995-05-18	Carlen Judith	Treating erectile dysfunction without causing side-effects
GB9614098D0 (en)	1996-07-05	1996-09-04	Orion Yhtymae Oy	Transdermal delivery of levosimendan
JP2003525845A (en) *	1997-10-28	2003-09-02	ヴィヴァス・インコーポレイテッド	Topical administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
FI974578A7 (en)	1997-12-19	1999-06-20	Orion Yhtymae Oyj	Method of administration of levosimendan
FI981473L (en)	1998-06-25	1999-12-26	Orion Yhtymae Oyj	Method for treating pulmonary hypertension

2000
- 2000-12-15 FI FI20002755A patent/FI20002755A0/en unknown
2001
- 2001-12-14 EP EP01270296A patent/EP1349551A2/en not_active Withdrawn
- 2001-12-14 US US10/450,304 patent/US7115604B2/en not_active Expired - Fee Related
- 2001-12-14 AU AU2002219247A patent/AU2002219247A1/en not_active Abandoned
- 2001-12-14 WO PCT/FI2001/001101 patent/WO2002047603A2/en not_active Ceased
- 2001-12-14 CA CA002431125A patent/CA2431125C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FI20002755A0 (en)	2000-12-15
US7115604B2 (en)	2006-10-03
WO2002047603A2 (en)	2002-06-20
EP1349551A2 (en)	2003-10-08
WO2002047603A3 (en)	2003-01-30
CA2431125A1 (en)	2002-06-20
US20040063711A1 (en)	2004-04-01
CA2431125C (en)	2009-06-09

Similar Documents

Publication	Publication Date	Title
AU2002223827A1 (en)	2002-05-27	Well treatment
AU2001285159A1 (en)	2002-05-06	Methods for treating endocrine disorders
AU2001269939A1 (en)	2002-01-02	Methods for eliminating the formation of biofilm
ZA200107291B (en)	2003-02-26	Use of xenon for treating neurointoxications.
AU2002215125A1 (en)	2002-05-27	Well treatment method
AU2001286983A1 (en)	2002-03-13	Method of treatment
AU3928302A (en)	2002-06-03	Improved shower apparatus
AU2001222215A1 (en)	2002-07-01	Lumbago treating girdle
AU2001228703A1 (en)	2001-08-14	Use of cox-2 inhibitors for the treatment of constipation
AU2001237939A1 (en)	2001-08-20	Methods for treating glaucoma
AUPQ761400A0 (en)	2000-06-15	Removal of toxins from water
AU2001293891A1 (en)	2002-04-15	New combination for the treatment of asthma
IL154642A0 (en)	2003-09-17	Treatment of urinary dysfunction
AU2001253836A1 (en)	2001-11-07	Method of treating cancer
HUP0302430A3 (en)	2009-08-28	Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
AU2001236929A1 (en)	2001-08-20	Surface treatment
AU2001262177A1 (en)	2001-10-23	Method of treatment
AU2000231423A1 (en)	2001-09-12	Specific therapeutic composition for treating aids
AU2002219247A1 (en)	2002-06-24	Use of levosimendan for treating erictile dysfunction
AU2001282349A1 (en)	2002-03-04	Fluid treatment
AU2002212876A1 (en)	2002-05-06	Method for integrated water treatment
AU2002228911A1 (en)	2002-05-21	Methods for inhibiting pain
AU2001281465A1 (en)	2001-09-24	Treatment of rosacea
AU2001253560A1 (en)	2001-10-30	Methods of treatment
AU2000272704A1 (en)	2002-03-26	Use of compounds for the treatment of obesity